Title: Development of CoMFA and CoMSIA models of affinity and selectivity for indole ligands of cannabinoid CB1 and CB2 receptors.
Journal: European journal of medicinal chemistry 20090601
209414-06-2
824959-87-7
824960-56-7
1354631-24-5
1131605-25-8
1358118-35-0
807295-35-8 | 2,4-IMIDAZOLIDINEDIONE, 5-(4-PIPERIDINYL)- | AA00GEUA | MFCD11111767
749845-76-9 | Benzyl-methyl-piperidin-4-ylmethyl-amine | AA00GHKZ | MFCD05215188
807343-04-0 | [(2-Bromophenyl)methyl](propyl)amine | AA00GLEU | MFCD09943267
763131-38-0 | 4-Bromo-2-(((4-isopropylphenyl)amino)methyl)-6-methoxyphenol | AA00GN41 | MFCD05155005
808737-30-6 | 2H-1,4-Diazepin-2-one,3-ethylhexahydro-(9CI) | AA00GQYG | MFCD18814224
914348-87-1 | 4-(3,4-Dihydro-1h-isoquinolin-2-yl)-3-trifluoromethylphenylamine | AA00GRF7 | MFCD04117869
9064-57-7 | GAMMA-CARRAGEENAN | AA00GROS | MFCD00151513
885950-24-3 | N'-Hydroxyimidazo[1,2-a]pyridine-6-carboximidamide | AA00GRVY | MFCD07366550
915720-54-6 | 1-(5-Fluoropyridin-2-yl)ethanone | AA00GS43 | MFCD10698609
914452-71-4 | 2-Bromo-6-methylpyrazine | AA00GSES | MFCD08705760
Journal: European journal of medicinal chemistry20090601